A method for inferring regional origins of neurodegeneration
暂无分享,去创建一个
Pedro D. Maia | Ashish Raj | Sneha Pandya | Fon Powell | Pedro D Maia | Justin Torok | A. Raj | Fon Powell | S. Pandya | Justin Torok | P. Maia
[1] H. Braak,et al. Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert , 2000, Acta Neuropathologica.
[2] Ninon Burgos,et al. New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .
[3] Zeshan Ahmed,et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.
[4] Efstathios D. Gennatas,et al. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.
[5] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[6] G Forster,et al. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.
[7] John C. Morris,et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure , 2017, NeuroImage.
[8] D. Na,et al. Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease , 2017, Neurobiology of Aging.
[9] Philip S. Insel,et al. Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease , 2013, PloS one.
[10] C. Jack,et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.
[11] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.
[12] J. Baron,et al. In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.
[13] Stefan Klöppel,et al. Gray matter atrophy pattern in elderly with subjective memory impairment , 2014, Alzheimer's & Dementia.
[14] A. Raj,et al. Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease , 2017, Acta Neuropathologica Communications.
[15] S. A. Hussaini,et al. Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.
[16] Bruce Fischl,et al. Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.
[17] J. Trojanowski,et al. Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers , 2013, NeuroImage: Clinical.
[18] Anders M. Dale,et al. Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.
[19] Corinne E. Fischer,et al. Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions , 2016, International journal of geriatric psychiatry.
[20] Norbert Schuff,et al. Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns , 2017 .
[21] Bill Seeley,et al. Neurodegenerative diseases target large-scale human brain networks , 2010, Alzheimer's & Dementia.
[22] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[23] Daniel C. Alexander,et al. Camino: Open-Source Diffusion-MRI Reconstruction and Processing , 2006 .
[24] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[25] J. Trojanowski,et al. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections , 2015, Acta Neuropathologica.
[26] H. Braak,et al. The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei , 2000, Neuropathology and applied neurobiology.
[27] J. Trojanowski,et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers , 2016, Brain : a journal of neurology.
[28] Alan C. Evans,et al. Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..
[29] Sang Won Seo,et al. Anatomical heterogeneity of Alzheimer disease , 2014, Neurology.
[30] Murray Grossman,et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. , 2002, The American journal of pathology.
[31] Michael Weiner,et al. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.
[32] Paul M. Thompson,et al. Localizing Sources of Brain Disease Progression with Network Diffusion Model , 2016, IEEE Journal of Selected Topics in Signal Processing.
[33] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[34] Mark W. Woolrich,et al. FSL , 2012, NeuroImage.
[35] J. Schott,et al. Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[36] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[37] Kiralee M. Hayashi,et al. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. , 2007, Archives of neurology.
[38] R. Mayeux,et al. Memory performance is related to amyloid and tau pathology in the hippocampus , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[39] Alan C. Evans,et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.
[40] Keith A. Johnson,et al. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.
[41] K. Jellinger,et al. The relationship between subcortical tau pathology and Alzheimer's disease. , 2012, Biochemical Society transactions.
[42] K. Jellinger,et al. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.
[43] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[44] H. Braak,et al. Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.
[45] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[46] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.